| Gary Nakashima, PHARMD | |
|
2037 Verdugo Blvd, Montrose, CA 91020-1626 | |
| (818) 248-8018 | |
| Not Available |
| Full Name | Gary Nakashima |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2037 Verdugo Blvd, Montrose, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912436783 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 70477 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gary Nakashima, PHARMD 2037 Verdugo Blvd, Montrose, CA 91020-1626 Ph: () - | Gary Nakashima, PHARMD 2037 Verdugo Blvd, Montrose, CA 91020-1626 Ph: (818) 248-8018 |
News Archive
Researchers at the OHSU Oregon National Primate Research Center (ONPRC) have identified a key gene that impacts the timing of puberty and can shorten the time span for reproduction.
Patients 65 and older who have ambulatory surgery are much more likely to be readmitted to the hospital within 30 days than younger patients, regardless of their health before surgery, reports a new, large national Northwestern Medicine study. The likely cause, based on previous research, is difficulty understanding medication dosing and discharge instructions, as well as cognitive impairment among older patients.
Early next year 10,000 abused women across Spain are due to receive a prototype personal alarm system operated by Vodafone and the Red Cross. The system stems from the results of CONFIDENT, which developed mobile services to enhance the independence of people with special needs.
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
› Verified 5 days ago
Mania Gharibian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Zohrab Khacheryan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 323-333-4074 | |
Nicole Ouzounian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Thuan Minh Hoang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Garo Boyajian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Erebooni Annie Aslanian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2037 Verdugo Blvd, Montrose, CA 91020 Phone: 818-248-8018 | |
Dr. Renia Shahjahanian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2727 Montrose Ave Apt 5, Montrose, CA 91020 Phone: 818-468-9311 |